PITTSBURGH, April 05, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) (“Lipella,” “our”, “us” or the “Company”), a clinical-stage ...
2d
Cash Position: Ended Q1 2024 with $714.3 million in cash, cash equivalents, and marketable securities, down from $806.4 ...
If you are interested in combining chemistry, biology, mathematics and computer techniques with pharmacology, physiology and biochemistry, to work on the development of treatments to prevent disease ...
Q1 2024 Earnings Call Transcript May 2, 2024 Ultragenyx Pharmaceutical Inc. misses on earnings expectations. Reported EPS is ...
Infected Bloody Inquiry is to report on mistakes that led to 1,250 people in UK contracting HIV and 5,000 more contracting ...
like vaccines and new treatments that have been developed in a short period of time, have been used to try and ease the pandemic. (Pharmaceutical manufacturers are a subset of this industry and are ...
The Pharma Quality Excellence Awards 2024 scheduled for April 26th in Hotel Novotel, Airport Road, Mumbai, is a prestigious event aimed at recognizing and celebrating the exceptional achievements of ...
This program is designed to prepare pharmacists for careers in pharmaceutical education, research, industry and related areas of specialized practice. Pharmaceutical Sciences focuses on cutting-edge ...
Novartis has started cutting ties with Chinese contractors amid a potential threat from the BIOSECURE Act. | Novartis has ...
Aurinia Pharmaceuticals Inc. (NASDAQ ... Let's take a few minutes and go into detail regarding our financial results for the ...
PITTSBURGH, April 05, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) (“Lipella,” “our”, “us ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback